INSIDER · CIK 2014440
Anderson Woodrow D
Chief Accounting Officer at Indivior Pharmaceuticals, Inc. (INDV)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$108KBought on the market
$0.00Sold on the market
1Companies
Aug 27, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 202616:00 | Aug 27, 2026 | INDVIndivior Pharmaceuticals, Inc. | Chief Accounting Officer | P · Buy | $35.69 | +1,500 | 27,638 | +6% | +$54K | -14.7% | -1.2% |
| Aug 5, 202616:52 | Aug 5, 2026 | INDVIndivior Pharmaceuticals, Inc. | Chief Accounting Officer | P · Buy | $36.28 | +1,500 | 26,138 | +6% | +$54K | -13.3% | -2.8% |